- Home
- GDTC vs MBBC Comparison
GDTC vs MBBC Comparison
Compare GDTC & MBBC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GDTC
- MBBC
- Stock Information
- Founded
- GDTC 2018
- MBBC 1902
- Country
- GDTC Singapore
- MBBC United States
- Employees
- GDTC N/A
- MBBC N/A
- Industry
- GDTC Biotechnology: Pharmaceutical Preparations
- MBBC Banks
- Sector
- GDTC Health Care
- MBBC Finance
- Exchange
- GDTC Nasdaq
- MBBC Nasdaq
- Market Cap
- GDTC 28.0M
- MBBC 29.3M
- IPO Year
- GDTC 2023
- MBBC N/A
- Fundamental
- Price
- GDTC $2.21
- MBBC $10.03
- Analyst Decision
- GDTC Buy
- MBBC
- Analyst Count
- GDTC 1
- MBBC 0
- Target Price
- GDTC $5.00
- MBBC N/A
- AVG Volume (30 Days)
- GDTC 6.6K
- MBBC 9.9K
- Earning Date
- GDTC 01-01-0001
- MBBC 08-22-2025
- Dividend Yield
- GDTC N/A
- MBBC N/A
- EPS Growth
- GDTC N/A
- MBBC 103.56
- EPS
- GDTC N/A
- MBBC 0.22
- Revenue
- GDTC $368,838.00
- MBBC $6,591,743.00
- Revenue This Year
- GDTC $5.37
- MBBC N/A
- Revenue Next Year
- GDTC N/A
- MBBC N/A
- P/E Ratio
- GDTC N/A
- MBBC $45.49
- Revenue Growth
- GDTC N/A
- MBBC N/A
- 52 Week Low
- GDTC $1.20
- MBBC $6.38
- 52 Week High
- GDTC $4.05
- MBBC $12.00
- Technical
- Relative Strength Index (RSI)
- GDTC 49.36
- MBBC N/A
- Support Level
- GDTC $2.09
- MBBC N/A
- Resistance Level
- GDTC $2.35
- MBBC N/A
- Average True Range (ATR)
- GDTC 0.10
- MBBC 0.00
- MACD
- GDTC 0.00
- MBBC 0.00
- Stochastic Oscillator
- GDTC 50.00
- MBBC 0.00
About GDTC CytoMed Therapeutics Limited
CytoMed Therapeutics Ltd is a pre-clinical biopharmaceutical company focused on harnessing its proprietary technologies to create novel cell-based immunotherapies for the treatment of human cancers. The development of its novel technologies has been inspired by the clinical success of existing CAR-T cells in treating hematological malignancies as well as the current clinical limitations and commercial challenges in extrapolating the CAR-T principle into the treatment of solid tumors. Geographically, the company operates in Singapore and Malaysia which is the majority revenue generator.
About MBBC Marathon Bancorp Inc. Common Stock
Marathon Bancorp Inc is a Wisconsin-chartered savings bank. It is a community-oriented bank offering a variety of financial products and services to meet the needs of customers. The primary deposit products are demand deposits, savings, and certificates of deposits; and prime lending products are commercial real estate, commercial and industrial, construction, one-to-four-family residential, multifamily real estate, and consumer loans. The majority of the Company's revenues come from interest income on loans and debt securities.